Format

Send to:

Choose Destination
See comment in PubMed Commons below
Best Pract Res Clin Haematol. 2007 Sep;20(3):469-77.

Revision of the guidelines for diagnosis and therapy of chronic lymphocytic leukemia (CLL).

Author information

  • 1Klinik I für Innere Medizin, Universität zu Köln, Kerpenerstr. 62, D-50924 Köln, Germany.

Abstract

During the past 10 years, significant progress has been achieved in defining new prognostic markers, diagnostic parameters, and treatment options in chronic lymphocytic leukemia (CLL). These developments have led to revision of the National Cancer Institute-sponsored Working Group (NCI-WG) guidelines on CLL established in 1988 and 1996. The update of these guidelines will clarify the role of new prognostic markers in CLL, improve the definitions of response and refractory disease, and add information on the prevention and management of infectious and autoimmune complications.

PMID:
17707834
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk